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Introduction
Gastroschisis is a congenital defect, which affects five in 10,000 live births 1 , characterized by an opening on the abdominal wall and exposition of bowel loops which are in contact with amniotic fluid (AF) causing a intense inflammation and changes in the intestinal morphology, affecting motility and nutrients absorption 2 .
The prevention or reduction of inflammatory bowel injury has been the subject of recent research in the treatment of gastroschisis. The experimental administration of corticosteroids promotes beneficial effects on fetal intestinal and lung development 3, 4 .
In addition to acting on the development, corticosteroids (eg. Dexamethasone) may be potent anti-inflammatory agents;
they can also act in the downregulation of proinflammatory and upregulation of anti-inflammatory cytokines when administered prior to cardiac surgery in neonates 5 . These actions can also be extended to fetuses when the corticosteroid is administered to the mother, because it is able to accelerate the maturation of the intestinal mucosal barrier, as well as to increase the activity of some enzymes 6 , acting on the membrane permeability, enzymatic synthesis and mucosa transport.
By inhibiting the synthesis and release of IL-1, corticosteroids also suppress activation of Th cells, thus reducing toxicity and inhibiting the synthesis of various cytokines, such as TNF-a and IFN-g. These inflammatory mediators present in gastroschisis, especially the cytokine profile in fetal tissues, have not been well studied 7 .
Thus, to better understand the inflammatory response in gastroschisis and the corticosteroids action in the defect, pro and anti-inflammatory cytokines (IL-1, IL-6, IL-10, TNF-a and IFN-g) were quantified in the model of experimental gastroschisis in rats fetuses to ascertain which interleukins have changed.
Methods
An experimental protocol was submitted to and approved by the State University of Campinas (UNICAMP) Animal
Research Committee and followed guidelines for the care and use of laboratory animals, internal number 281-1.
Surgery and sample collection
Sprague-Dawley female rats (n= 10), weighing 200 to 250g, were mated and a vaginal smear to confirm mating was performed on the following day. C fetuses were left undisturbed and S fetuses were exposed by histerotomy, manipulated but without abdominal wall opening.
There were 6 fetuses in each sub-group. The first and last fetuses of each uterine horn were not used. The selection was planned:
the second fetus, number 1 to be operated, was G; number 2-C; number 3-S; and so on. Each pregnant rat had at least two fetuses submitted to gastroschisis.
Fetuses were harvested by cesarean section on 21.5 day of gestation and then sacrificed by occipital puncture and a lethal dose of anesthetic. The intestinal tract and the liver were removed and immediately frozen for enzyme-linked immunosorbent assay (ELISA).
Immunoprecipitation and ELISA assay
Intestinal samples were homogenized in a immunoprecipitation buffer containing 1% Triton X 100, 100 mM Tris (pH 7.4), 100mM sodium de pyrophosphate, 100mM sodium fluoride, 10mM EDTA, 10mM sodium vanadate, 2mM PMSF and 0.1 mg/mL aprotinin at 4º C. The homogenate was then centrifuged at 11,000 rpm for 20 minutes. In the supernatant, protein concentration was analyzed by the Lowry method and, afterwards, pro-inflammatory IL-1, IL-6, TNF-a e IFN-g and anti-inflammatory IL-10 cytokine levels were obtained on the total protein intestinal tissue extract (2.0 mg/ml) through ELISA (Pierce Biothecnology, Rockford, IL, USA), accondingly to manufacturer's recommendation.
Statistical analysis
Statistical analysis was performed using ANOVA test with Tukey's post-test and the statistical significance accepted was p<0.05.
Results
The used technique has been shown to be reliable, and there was neither fetal nor maternal mortality. G fetuses showed remarkable inflammatory intestines, with adhesions between loops and covered by a peel, very similar to that of the human anomaly.
Dx led to an increase of IL-6 and a decrease of TNF-a levels on the intestine of gastroschisis fetuses, and an increase of IL-6 levels on the liver of theses fetuses.
Results of intestinal and hepatic IL1, IL6, IL10, TNF-a and IFN-g with or without additional administration of corticosteroid are condensed in Table 1 and 2, respectively. These results demonstrate that cytokines may not be the most suitable parameter for diagnosing inflammatory intensity that occurs in a tissue or in the fetal body as a whole. A recent study in surgical patients, including gastroschisis, showed that C-reactive protein (CRP), produced by the liver, is an extremely sensitive indicator of inflammation. In addition, corticosteroids treatment did not affect the production of CRP, enabling to quantify them due to the level of inflammation and not for direct intervention in its expression 13 .
The CRP expression can take longer to normalize due to chronic inflammation, which was does not happen with other inflammatory mediators such as IL-1b, IL-6, IL-8, IL-10 and TNF, that doesn't change their levels, and therefore are not useful to monitor a postoperative period, except for that IL-6 increases during 24 hours after a surgical procedure, but returns to its basal levels afterwards 13 .
Moreover, it may not have been possible to identify the interleukin pattern change due to the 48 hours time gap between surgery for gastroschisis and harvest. This monitoring can be accomplished by harvesting at the age of 20.5 days of gestation and finally comparing with term pups.
A better understanding of intrauterine intestinal inflammation could benefit the prognosis and treatment of neonates, not only with gastroschisis, but also with other defects such as myelomeningocele.
Conclusions
Corticosteroids had an effect on the intestinal interleukin profile and a small effect on the liver interleukin profile due to immunological immaturity of the fetus, and also of fetuses with gastroschisis. The steroid action may not be exclusively antiinflammatory, but also pro-inflammatory, varying with time of pregnancy. Perhaps, assessing in shorter gestational intervals and serially could provide new insights for understanding the steroid action on the interleukin profile in this model.
